Gilead Sciences, Inc. (NASDAQ: GILD) today announced positive topline results from the Phase 3 ARTISTRY-1 trial. The ...

Gilead Sciences (GILD) announced on Thursday that its Phase 3 ARTISTRY-1 trial, which tested its new single-tablet regimen of ...

The trial evaluated treatment responses in patients who were virologically suppressed, switching from a multi-tablet regimen ...

Anthropic announces $50 billion investment in building AI data centers in the US. These centers will go live in Texas and New ...

Google confirms a new advanced flow for Android, allowing experienced users to bypass new developer verification rules and ...

Over the past few months, Verizon has landed in hot water for a number of pricing changes that it enforced, which resulted in ...

The experts consulted for this story do not necessarily endorse the products ahead unless otherwise noted.

An expensive 3Gbps internet plan hardly matters if your Wi-Fi is overloaded. In a few years, 3Gbps might seem pathetic, given ...

Investing.com -- Gilead Sciences Inc (NASDAQ:GILD) stock rose 2.7% on Thursday after the company announced positive topline ...

From Egypt to Kazakhstan, the foreign assets of Russian oil major Lukoil are attracting potential bidders as time runs out to ...

Pope Leo has revealed his four favorite films: It's a Wonderful Life (1946), The Sound of Music (1965), Ordinary People (1980 ...

Digital transformation sits at the heart of the NHS Long Term Plan, promising a more connected, efficient, and ...